Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

Share Price is delayed by 15 minutes
Get Live Data
113.50    0.00 (0.00%)
Bid:
110.00
Ask:
117.00
Spread: 7.00 (6.364%)
Market Cap: £15.31m
ITX Live PriceLast checked at - London Stock Exchange

Intraday Itaconix Plc Share Chart

AGM Statement

19 May 2016 07:00

RNS Number : 6672Y
Revolymer PLC
19 May 2016
 

19 May 2016

Revolymer plc ("Revolymer" or "the Company")

AGM Statement

At the Annual General Meeting of the Company being held today, Dr Bryan Dobson, Chairman of the Company will make the following comments:

"Trading in the first quarter of the current financial year is in line with our expectations, and we have continued to make good progress in gaining commercial traction with our product pipeline. In the Personal and Consumer Health Care market, our new line of natural hair styling polymers, RevCareTM Natural Effects, was well received at its product launch at the Paris InCosmetics trade show in April 2016. In the Home Care and Industrial market, RevCoatTM Bond, our novel polymeric adhesion promoter for high performance sealants and adhesives, is due for launch later in the second quarter of 2016. As announced on 25 January 2016, we have also secured a renewal and expansion of our contract to supply nicotine gum in Canada, as well as contracting with a new customer in Canada. 

This commercial progress follows on from our milestones in 2015, including two significant licence deals in our Home Care and Industrial business area (with Solvay and OCI). The Company is now positioned as a specialty chemicals business, focussed on controlled release, responsive systems and delivery systems that improve the functional performance of our customers' products in two high value business areas: Personal and Consumer Health Care and Home Care and Industrial, and we have aligned the organisation so that we are best placed to penetrate these markets.

Considering the remainder of 2016 and beyond, I look forward to continued commercial milestones being achieved in both our business areas, and management remains receptive to executing corporate transactions as a route to developing the business in parallel with its ongoing organic growth."

 

Ends

 

For further information please contact:

Revolymer plc

+44 (0) 1244 283 500

Kevin Matthews / Rob Cridland

 

 

Panmure Gordon (UK) Limited

+44 (0) 20 7886 2500

Adam James / Fabien Holler (Corporate Finance)

Charles Leigh-Pemberton (Corporate Broking)

 

 

About Revolymer

Revolymer is an AIM quoted company (registered number 08024489) whose vision is to be a specialty chemicals business focused on controlled release, responsive systems and delivery systems based on its expertise in the design and synthesis of polymers that improve the functional performance of its customers' products, thereby generating high margin business.

www.revolymer.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBCGDUUBBBGLI
Date   Source Headline
4th Apr 20177:00 amRNSPreliminary Results Announcement - Replacement
27th Mar 20177:00 amRNSFinal Results
1st Mar 20177:00 amRNSChange of Name to Itaconix plc
10th Feb 20177:00 amRNSHolding(s) in Company
1st Feb 20171:33 pmRNSTotal Voting Rights
27th Jan 201711:53 amRNSJoint development agreement with AkzoNobel
23rd Jan 20177:00 amRNSExclusive Supply & Marketing Agreement with Croda
9th Jan 20177:00 amRNSBlock listing Interim Review
3rd Jan 20177:00 amRNSChange of Adviser
30th Dec 20169:22 amRNSDirectorate Change
2nd Nov 20161:18 pmRNSDivestment of Nicotine Gum Business
14th Oct 20167:00 amRNSDirector/PDMR Shareholding
6th Oct 20167:00 amRNSDirector/PDMR Shareholding
30th Sep 20167:00 amRNSDirector/PDMR Shareholding
22nd Sep 20167:00 amRNSInterim Results
19th Sep 20167:00 amRNSDivestment of Nicotine Gum Business
13th Sep 201611:34 amRNSDirectorate Change
7th Sep 20167:00 amRNSFirst Commercial Sales of Itaconix® CHTT
1st Aug 201611:33 amRNSTotal Voting Rights
15th Jul 20168:04 amRNSHolding(s) in Company
11th Jul 20164:34 pmRNSHolding(s) in Company
11th Jul 20163:35 pmRNSBlock listing Interim Review
8th Jul 201611:55 amRNSResult of General Meeting
8th Jul 20167:00 amRNSSuccessful Application for Accelerated Whitewash
22nd Jun 20164:29 pmRNSPosting of Circular and Notice of General Meeting
21st Jun 20162:24 pmRNSResults of Placing
21st Jun 20167:00 amRNSAcquisition & Placing
20th Jun 20165:31 pmRNSAcquisition & Placing
19th May 20162:33 pmRNSResult of AGM
19th May 20167:00 amRNSAGM Statement
7th Apr 20167:00 amRNSNotice of AGM & Posting of Annual Report
1st Apr 20167:00 amRNSTotal Voting Rights
21st Mar 20167:00 amRNSFinal Results
16th Mar 20167:00 amRNSDirectorate Change
1st Mar 20168:41 amRNSTotal Voting Rights
25th Jan 20167:00 amRNSRenewed & Expanded Contract
11th Jan 20167:00 amRNSBlocklisting Interim Review
30th Nov 20155:21 pmRNSHolding(s) in Company
30th Nov 20157:00 amRNSTotal Voting Rights
30th Oct 201512:30 pmRNSTotal Voting Rights
21st Sep 20157:00 amRNSInterim Results
18th Sep 20157:00 amRNSDirectorate Change
7th Sep 201512:18 pmRNSTotal Voting Rights
2nd Sep 20157:00 amRNSBlocklisting Interim Review
1st Sep 20157:03 amRNSLicence with OCI Alabama LLC
15th Jun 201512:27 pmRNSHolding(s) in Company
3rd Jun 20157:00 amRNSGlobal licence signed with Solvay
20th May 201512:17 pmRNSResult of AGM
15th May 20151:21 pmRNSHolding(s) in Company
15th May 20151:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.